McDaniel Terry & Co’s Halozyme HALO Stock Holding History

McDaniel Terry & Co’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,071	Closed	-$267K	–	92
2022 Q2	$267K	Hold	6,071	–	–	0.03%	83
2022 Q1	$242K	Buy	+6,071	New	+$216K	0.03%	88

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

McDaniel Terry & Co's HALO Position: Q3 2022 in Review

McDaniel Terry & Co sold out of Halozyme (HALO) in Q3 2022, closing a stake of 6,071 shares — an estimated $267K sold.

McDaniel Terry & Co first reported a position in HALO in Q1 2022 and held it in 2 quarters. The position peaked at $267K in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

McDaniel Terry & Co reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
McDaniel Terry & Co sold 6,071 Halozyme shares in Q3 2022, an estimated $267K.
McDaniel Terry & Co first reported a position in Halozyme in Q1 2022 and held it in 2 quarters.
McDaniel Terry & Co's Halozyme position peaked at $267K in Q2 2022.
357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on McDaniel Terry & Co's 13F filing for Q3 2022, filed 6 Oct 2022.